Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia R Trosman

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Personalized Medicine|May 23, 2018
Company Profile: Center for Business Models in HealthcareJulia R Trosman, Christine B Weldon
JAMA|May 31, 2019
Emergence of Hybrid Models of Genetic Testing Beyond Direct-to-Consumer or Traditional LabsKathryn A Phillips, Julia R Trosman, Michael P Douglas
The American Journal of Managed Care|June 30, 2011
Health technology assessment and private payers's coverage of personalized medicineJulia R Trosman, Stephanie L Van Bebber, Kathryn A Phillips
Journal of Oncology Practice|September 3, 2011
Health technology assessment and private payers' coverage of personalized medicineJulia R Trosman, Stephanie L Van Bebber, Kathryn A Phillips
Journal of Oncology Practice|January 4, 2011
Coverage policy development for personalized medicine: private payer perspectives on developing policy for the 21-gene assayJulia R Trosman, Stephanie L Van Bebber, Kathryn A Phillips
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 19, 2017
"What Goes Around Comes Around": Lessons Learned from Economic Evaluations of Personalized Medicine Applied to Digital MedicineKathryn A Phillips, Michael P Douglas, Julia R Trosman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 5, 2015
Challenges of coverage policy development for next-generation tumor sequencing panels: experts and payers weigh inJulia R Trosman, Christine B Weldon, R Kate Kelley, et al.
Journal of Community Genetics|November 7, 2021
Hereditary cancer panel testing challenges and solutions for the latinx community: costs, access, and variantsMichael P Douglas, Grace A Lin, Julia R Trosman, et al.
JCO Precision Oncology|February 28, 2025
Implementation of Cancer Genomics in the United States: Views of Payers and Other Stakeholders on Challenges and the Role of Payers in SolutionsJulia R Trosman, Christine B Weldon, Allison W Kurian, et al.
Nature Biotechnology|September 9, 2015
Availability and payer coverage of BRCA1/2 tests and gene panelsElizabeth Clain, Julia R Trosman, Michael P Douglas, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Personalized Medicine|May 23, 2018
Company Profile: Center for Business Models in HealthcareJulia R Trosman, Christine B Weldon
JAMA|May 31, 2019
Emergence of Hybrid Models of Genetic Testing Beyond Direct-to-Consumer or Traditional LabsKathryn A Phillips, Julia R Trosman, Michael P Douglas
The American Journal of Managed Care|June 30, 2011
Health technology assessment and private payers's coverage of personalized medicineJulia R Trosman, Stephanie L Van Bebber, Kathryn A Phillips
Journal of Oncology Practice|September 3, 2011
Health technology assessment and private payers' coverage of personalized medicineJulia R Trosman, Stephanie L Van Bebber, Kathryn A Phillips
Journal of Oncology Practice|January 4, 2011
Coverage policy development for personalized medicine: private payer perspectives on developing policy for the 21-gene assayJulia R Trosman, Stephanie L Van Bebber, Kathryn A Phillips
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 19, 2017
"What Goes Around Comes Around": Lessons Learned from Economic Evaluations of Personalized Medicine Applied to Digital MedicineKathryn A Phillips, Michael P Douglas, Julia R Trosman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 5, 2015
Challenges of coverage policy development for next-generation tumor sequencing panels: experts and payers weigh inJulia R Trosman, Christine B Weldon, R Kate Kelley, et al.
Journal of Community Genetics|November 7, 2021
Hereditary cancer panel testing challenges and solutions for the latinx community: costs, access, and variantsMichael P Douglas, Grace A Lin, Julia R Trosman, et al.
JCO Precision Oncology|February 28, 2025
Implementation of Cancer Genomics in the United States: Views of Payers and Other Stakeholders on Challenges and the Role of Payers in SolutionsJulia R Trosman, Christine B Weldon, Allison W Kurian, et al.
Nature Biotechnology|September 9, 2015
Availability and payer coverage of BRCA1/2 tests and gene panelsElizabeth Clain, Julia R Trosman, Michael P Douglas, et al.
Pageof 5